Gladstone Institutional Advisory LLC Tandem Diabetes Care Inc Transaction History

Gladstone Institutional Advisory LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $188,650 - $242,173	-2,321 Closed	0 $0
Q4 2020 Jan 27, 2023	SELL	$86.4 - $121.75 $184,982 - $260,666	-2,141 Reduced 47.98%	2,321 $222,000
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $184,982 - $260,666	-2,141 Reduced 47.98%	2,321 $222,000
Q3 2020 Jan 27, 2023	BUY	$95.43 - $116.09 $425,808 - $517,993	4,462 New	4,462 $506,000
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $3,626 - $4,411	38 Added 0.86%	4,462 $506,000
Q2 2020 Aug 17, 2020	BUY	$60.05 - $98.92 $39,332 - $64,792	655 Added 17.38%	4,424 $438,000
Q1 2020 May 14, 2020	BUY	$47.37 - $90.04 $178,537 - $339,360	3,769 New	3,769 $243,000

361

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.